LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $651,105 | +4.4% | 9,693,368 | +7.3% | 0.10% | +9.2% |
| Q2 2023 | $623,434 | +1083.8% | 9,031,324 | +726.9% | 0.09% | +987.5% |
| Q1 2023 | $52,665 | +61.2% | 1,092,149 | +66.9% | 0.01% | +60.0% |
| Q4 2022 | $32,674 | -99.9% | 654,519 | -0.2% | 0.01% | +25.0% |
| Q3 2022 | $26,757,000 | -14.2% | 655,798 | +15.6% | 0.00% | 0.0% |
| Q2 2022 | $31,194,000 | +765.3% | 567,155 | +356.5% | 0.00% | – |
| Q1 2021 | $3,605,000 | -77.9% | 124,229 | -78.6% | 0.00% | -100.0% |
| Q4 2020 | $16,327,000 | -9.7% | 579,777 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $18,075,000 | -50.0% | 585,508 | -31.0% | 0.00% | -60.0% |
| Q2 2020 | $36,134,000 | – | 849,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |